Skip to main content
Singapore
AIMenta
APAC

Google DeepMind Opens AlphaFold 3 Commercial API to APAC Pharmaceutical and Biotech Firms

Google DeepMind releases AlphaFold 3 API for commercial use, enabling APAC pharmaceutical and biotech firms to access protein structure prediction for drug discovery workflows — previously limited to academic researchers through the original AlphaFold Server.

AE By AIMenta Editorial Team ·
AIMenta editorial take

Google DeepMind releases AlphaFold 3 API for commercial use, enabling APAC pharmaceutical and biotech firms to access protein structure prediction for drug discovery workflows — previously limited to academic researchers through the original AlphaFold Server.

Google DeepMind has made the AlphaFold 3 protein structure prediction system available through a commercial API, marking the first time the technology is accessible to APAC pharmaceutical and biotech companies for production drug discovery workflows rather than academic research.

AlphaFold 3 extends the original system's capabilities beyond protein structure prediction to include protein-ligand interactions, protein-nucleic acid complexes, and small molecule binding site prediction — capabilities directly relevant to APAC drug discovery programmes targeting infectious diseases endemic to the region, including dengue fever, tuberculosis, and malaria variants.

For APAC pharmaceutical firms in Singapore, South Korea, and Japan — where significant domestic biotech sectors have developed around computational drug discovery — the commercial API removes the access barrier that previously restricted AlphaFold 3 to research institutions. APAC companies can now integrate protein structure prediction into their computational chemistry pipelines via API, with usage-based pricing that scales from early-stage target identification to late-stage lead optimisation. The commercial launch also signals that DeepMind's life sciences AI capabilities are transitioning from research demonstrations to enterprise software services in APAC markets.

Beyond this story

Cross-reference our practice depth.

News pieces sit on top of working capability. Browse the service pillars, industry verticals, and Asian markets where AIMenta turns these stories into engagements.

Tagged
#apac #ai #apac

Related stories